• Kantaro Receives EUA for Semi-Quantitative COVID-19 Antibody Test Kit americanpharmaceuticalreview
    December 14, 2020
    Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG ...
PharmaSources Customer Service